The global sterilization equipment and disinfectants market is estimated to be valued at approximately USD 19.2 Bn in 2026 and USD 29.9 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.6% during the forecast period. This is attributable to increasing focus on infection prevention, rising demand for sterilization in healthcare facilities, and growing use of advanced sterilization and disinfection technologies. According to the WHO, more than 300 million surgical procedures are performed each year globally, creating substantial demand for sterilization and reprocessing of medical instruments to ensure patient safety.
The global sterilization equipment and disinfectants market is poised to register steady growth during the forecast period. This growth is primarily driven by rising focus on infection prevention and control in healthcare settings, increasing healthcare-associated infections, increasing integration of automation and smart disinfection technologies, and growing need for effective sterilization and disinfection of medical instruments and equipment.
The World Health Organization (WHO) highlights healthcare-associated infections as a major challenge and emphasizes stronger infection prevention and control practices. This, in turn, is fueling demand for sterilization equipment and disinfectants. In addition, the CDC recommends sterilization of critical medical and surgical devices and disinfection of other patient-care equipment based on infection risk.
Sterilization is a process that destroys or eliminates all forms of microbial life using physical or chemical methods. In contrast, disinfection eliminates many or all pathogenic microorganisms on inanimate objects but generally does not destroy bacterial spores. Sterilization provides a broader level of microbial control than disinfection.
Autoclaves use pressurized steam to sterilize heat-resistant instruments, laboratory materials, and other suitable items. Different sterilization techniques offer distinct advantages depending on the material and application. For heat-sensitive materials that may be damaged by high temperatures, low-temperature sterilization methods, including chemical sterilization, are preferred.
Increasing need to prevent healthcare-associated infections (HAIs) supports the use of sterilization and disinfection in healthcare facilities. Greater emphasis on infection prevention and control is encouraging healthcare facilities to adopt reliable sterilization and disinfection systems. This is expected to boost growth of sterilization equipment and disinfectants market during the forecast period.
Increasing demand for advanced sterilization technologies is also supporting market growth. Healthcare providers are adopting technologies such as vaporized hydrogen peroxide, hydrogen peroxide gas plasma, ozone, and peracetic acid to sterilize devices that cannot withstand conventional steam sterilization.
Similarly, growing adoption of automated sterilization systems is set to boost revenue growth. Automated and digitally monitored systems help improve cycle consistency, reduce manual handling as well as support better sterilization monitoring, encouraging their adoption in modern healthcare facilities.
To capitalize on emerging opportunities, leading sterilization equipment manufacturers are introducing advanced solutions. For instance, in December 2025, Getinge introduced Automatiq, a new family of automated solutions for sterile reprocessing. The solutions are designed to help Central Sterile Services Departments (CSSDs) make reprocessing safer, more consistent as well as less labor-intensive.
Based on product type, sterilization equipment segment is set to account for a revenue share of 64% in 2026. This dominance can be attributed to widespread use of equipment such as autoclaves, hot air ovens, and filters in healthcare facilities for sterilizing medical instruments and materials.
Demand for sterilization equipment is also increasing due to the growing need for reliable and repeatable sterilization of reusable medical devices. Sterilization equipment helps healthcare facilities reduce the risk of infections and maintain safe clinical practices, supporting its widespread adoption.

To learn more about this report, Request Free Sample
According to Coherent Market Insights' sterilization equipment and disinfectants market analysis, chemical method is expected to lead the market with a share of 52% in 2026. This can be attributed to growing use of chemical sterilization for heat-sensitive medical devices that cannot withstand high temperatures used in steam or dry-heat sterilization. Chemical methods can help sterilize complex instruments while reducing the risk of heat-related damage.
Chemical sterilization is particularly useful for devices made from plastics, polymers, and other heat-sensitive materials used in healthcare settings. Increasing use of these devices, along with the need for effective infection control and safe sterilization of reusable medical equipment, is expected to support adoption of chemical sterilization methods during the forecast period.
For example, the U.S. FDA reports that more than 20 billion medical devices are sterilized using ethylene oxide (EtO) each year, representing approximately 50% of medical devices requiring sterilization. The FDA also notes that EtO is suitable for devices made from polymers and plastics because it can sterilize many devices without damaging them.
Increasing incidence of healthcare-associated infections (HAIs) is providing a strong impetus for the growth of sterilization equipment and disinfectants market. According to the World Health Organization (WHO), around 1 in 10 patients globally is affected by HAIs. This is increasing the need for effective sterilization and disinfection practices in hospitals and other healthcare facilities, thereby driving demand for sterilization equipment and disinfectants.
Rising adoption of EtO alternatives is an emerging trend in the sterilization equipment and disinfectants market. Increasing regulatory and environmental pressure to reduce ethylene oxide emissions is driving the development and adoption of alternative sterilization technologies, including vaporized hydrogen peroxide, radiation, and nitrogen dioxide. For example, the U.S. FDA is working with industry stakeholders to reduce reliance on EtO and support the development and evaluation of alternative sterilization technologies.
|
Current Event |
Description and its Impact |
|
FDA Adds New Disinfectant Device Classification – 2026 |
|
|
WHO 2026 Campaign Highlights Infection Prevention |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report

To learn more about this report, Request Free Sample
America is expected to retain its dominance over the global sterilization equipment and disinfectants market, accounting for a share of 37.00% in 2026. This is attributable to high healthcare spending, stringent infection-control standards, and increasing use of sterilization and disinfection technologies in hospitals and other healthcare facilities.
High burden of healthcare-associated infections (HAIs) is a major factor fueling demand for sterilization and disinfectants in the region. According to the WHO, 7 out of every 100 patients in acute-care hospitals in high-income countries acquire at least one HAI during their hospital stay. Effective sterilization and disinfection are therefore essential to reduce infection risks and support patient safety.
Asia Pacific sterilization equipment and disinfectants market is anticipated to register a CAGR of 6.6% during the forecast period. This is mostly due to expanding healthcare infrastructure, rising surgical procedures, increasing focus on infection prevention, and growing adoption of modern sterilization technologies.
Growing need to prevent healthcare-associated infections is boosting sales of sterilization equipment and disinfectants in the region. The more than twice the rate reported in high-income countries. This highlights the need for stronger infection-prevention practices, including effective sterilization and disinfection of medical equipment.
The United States is projected to remain a prominent market for sterilization equipment and disinfectants during the assessment period. This is mainly due to high volume of surgical and invasive medical procedures, strict infection-control practices, and growing adoption of advanced low-temperature sterilization technologies. The U.S. performs approximately 46.5 million surgical procedures annually, creating sustained demand for reliable sterilization and disinfection solutions.
China is emerging as the most lucrative market for sterilization equipment and disinfectant companies. This is attributable to expansion and modernization of healthcare facilities, increasing adoption of advanced medical devices, rising surgical activity as well as greater emphasis on hospital infection prevention. The country's growing healthcare infrastructure is also supporting demand for automated and efficient sterilization and disinfection systems.
Some of the major players in sterilization equipment and disinfectants Market are 3M Company, STERIS Corporation, Getinge Group, Cantel Medical Corporation, Andersen Products Inc., Advanced Sterilization Products, and HARTMANN GROUP.
Leading manufacturers of sterilization equipment and disinfectants are adopting various organic and inorganic strategies to boost their revenue as well as gain a competitive edge in the industry. These include new product launches and approvals, increasing investments in R&D, acquisitions, partnerships, collaborations, mergers, and distribution agreements.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 19.2 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.6% | 2033 Value Projection: | USD 29.9 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
3M Company, STERIS Corporation, Getinge Group, Cantel Medical Corporation, Andersen Products Inc., Advanced Sterilization Products, and HARTMANN GROUP |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Share
Share
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients